Overestimated renal function in patients with liver cirrhosis predicts poor prognosis. Issue 7 (19th April 2022)
- Record Type:
- Journal Article
- Title:
- Overestimated renal function in patients with liver cirrhosis predicts poor prognosis. Issue 7 (19th April 2022)
- Main Title:
- Overestimated renal function in patients with liver cirrhosis predicts poor prognosis
- Authors:
- Yoshida, Sonoe
Suda, Goki
Ohara, Masatsugu
Kimura, Megumi
Yang, Zijian
Maehara, Osamu
Fu, Qingjie
Hosoda, Shunichi
Akinori, Kubo
Tokuchi, Yoshimasa
Yamada, Ren
Kitagataya, Takashi
Suzuki, Kazuharu
Kawagishi, Naoki
Nakai, Masato
Sho, Takuya
Natsuizaka, Mitsuteru
Morikawa, Kenichi
Ogawa, Koji
Ohnishi, Shunsuke
Sakamoto, Naoya - Abstract:
- Abstract: Aim: A high prevalence of overestimated renal function in patients with liver cirrhosis (LC) has been reported; nonetheless, its impact on prognosis remains unclear. We aimed to evaluate the impact of overestimated renal function on prognosis in patients with LC. Methods: An overestimated renal function was defined as a >20% increase in the creatinine‐based estimated glomerular filtration rate (eGFR), compared with cystatin C‐based eGFR. LC patients with conserved serum, who were evaluated for muscle atrophy and had proper clinical information were included, and their prognostic factors were analyzed. Results: A total of 215 consecutive patients with LC were included. The prevalence of overestimated renal function was 29.8% (64/215). Kaplan‐Meier survival analysis revealed that patients with overestimated renal function had a poorer prognosis than those without overestimated renal function (hazard ratio [HR]: 2.217 95% confidence interval [CI]: 1.290–3.810; p = 0.001). Subgroup analysis showed that overestimated renal function was a significant prognostic factor, irrespective of sex and the presence of hepatocellular carcinoma (HCC). Multivariate Cox regression analyses revealed that overestimated renal function was a significant and independent factor predictive of poor prognosis in the entire cohort (HR: 2.050; 95% CI: 1.041–4.037; p = 0.038) and in subgroups classified by Child‐Pugh class A (HR: 2.131; 95% CI: 1.019–4.458; p = 0.044), Model for End‐StageAbstract: Aim: A high prevalence of overestimated renal function in patients with liver cirrhosis (LC) has been reported; nonetheless, its impact on prognosis remains unclear. We aimed to evaluate the impact of overestimated renal function on prognosis in patients with LC. Methods: An overestimated renal function was defined as a >20% increase in the creatinine‐based estimated glomerular filtration rate (eGFR), compared with cystatin C‐based eGFR. LC patients with conserved serum, who were evaluated for muscle atrophy and had proper clinical information were included, and their prognostic factors were analyzed. Results: A total of 215 consecutive patients with LC were included. The prevalence of overestimated renal function was 29.8% (64/215). Kaplan‐Meier survival analysis revealed that patients with overestimated renal function had a poorer prognosis than those without overestimated renal function (hazard ratio [HR]: 2.217 95% confidence interval [CI]: 1.290–3.810; p = 0.001). Subgroup analysis showed that overestimated renal function was a significant prognostic factor, irrespective of sex and the presence of hepatocellular carcinoma (HCC). Multivariate Cox regression analyses revealed that overestimated renal function was a significant and independent factor predictive of poor prognosis in the entire cohort (HR: 2.050; 95% CI: 1.041–4.037; p = 0.038) and in subgroups classified by Child‐Pugh class A (HR: 2.131; 95% CI: 1.019–4.458; p = 0.044), Model for End‐Stage Liver Disease score ≤9 (HR: 2.303; 95% CI: 1.038–5.109; p = 0.04), and presence of HCC (HR: 2.290; 95% CI: 1.128–4.651; p = 0.022). Conclusion: Overestimated renal function is a significant and independent prognostic factor in patients with LC. … (more)
- Is Part Of:
- Hepatology research. Volume 52:Issue 7(2022)
- Journal:
- Hepatology research
- Issue:
- Volume 52:Issue 7(2022)
- Issue Display:
- Volume 52, Issue 7 (2022)
- Year:
- 2022
- Volume:
- 52
- Issue:
- 7
- Issue Sort Value:
- 2022-0052-0007-0000
- Page Start:
- 603
- Page End:
- 613
- Publication Date:
- 2022-04-19
- Subjects:
- creatinine -- cystatin C -- hepatocellular carcinoma -- liver disease -- muscle atrophy -- overestimation of renal function
Liver -- Diseases -- Periodicals
Liver Diseases -- Periodicals
Foie -- Maladies -- Périodiques
616.362 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09284346 ↗
http://firstsearch.oclc.org/journal=1386-6346;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1872-034X ↗
http://www.sciencedirect.com/science/journal/13866346 ↗
http://www3.interscience.wiley.com/journal/118507311/home ↗
http://www.blackwell-synergy.com/rd.asp?goto=journal&code=hep ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/hepr.13765 ↗
- Languages:
- English
- ISSNs:
- 1386-6346
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4295.845000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22277.xml